- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- April 2025
- 184 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 181 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 192 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 120 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- May 2025
- 118 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- August 2025
- 116 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- May 2025
- 149 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Drug Pipelines
- July 2025
- 280 Pages
Global
From €2627EUR$3,000USD£2,280GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Report
- August 2025
- 143 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- June 2025
- 189 Pages
Global
From €3941EUR$4,500USD£3,421GBP

The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more